Dr. Aimee McRae-Clark is a Doctor of Pharmacy and is board-certified in psychiatric pharmacy. She specializes in treatment development for cannabis use disorders, and has over fifteen years of experience in the clinical substance abuse research field. She provides general oversight for the studies.
Dr. Kevin M. Gray is a board-certified child, adolescent, and adult psychiatrist who has dedicated his career to developing novel treatments for substance use disorders in adolescents and young adults. With over ten years of experience in clinical research, Dr. Gray shares responsibility with Dr. McRae-Clark for the conduct of the studies and also provides medication monitoring to study participants.
Dr. Greg Sahlem is a board-certified psychiatrist with several years of experience in addiction research. His primary area of interest is the application of brain stimulation based treatments to substance use disordered populations.
Dr. Brian Sherman is a licensed clinical psychologist with expertise in evidence-based treatments for addiction. He provides psychiatric evaluations and monitoring of study participants, and conducts therapy interventions.
Ms. Wagner is a Licensed Professional Counselor with several years of experience in the substance abuse field. She coordinates study procedures and conducts diagnostic assessments and therapy interventions.